Literature DB >> 25344769

Coronary artery disease as an independent predictor of survival in patients with type 2 diabetes and Charcot neuro-osteoarthropathy.

Dominik Bergis1, Pia Maria Bergis, Norbert Hermanns, Karl Zink, Thomas Haak.   

Abstract

AIMS: Charcot neuro-osteoarthropathy (CN) is a rare complication of diabetic foot syndrome associated with chronic inflammation of the foot and severe, limb-threatening musculoskeletal deformities. Aim of this study was to investigate patients with CN for comorbidities, amputations, ulcers, secondary diseases and mortality.
METHODS: The study was conducted at a specialized German hospital for patients with diabetes. One-hundred and eleven patients were enrolled, and their course was followed over a period of 15 years. Association of CN with comorbidity, foot ulcers, amputations and mortality was assessed. Clinical course of patients was followed using two standardized questionnaires.
RESULTS: Presence of CN was significantly associated with diabetic retinopathy (p = 0.047), plantar (p < 0.001), tarsal (p = 0.032) and middle-foot ulcers (p = 0.01). A significant correlation between the presence of CN and a history of amputations was seen (p = 0.022). Patients were at increased risk to suffer from subsequent amputations during follow-up when micro- and macrovascular comorbidities such as retinopathy (p = 0.01) and peripheral artery disease (p < 0.001) were present. Additionally, coronary artery disease (CHD) was identified as an independent predictor of mortality in the cohort of this study (OR 6.192, 95 % CI 1.155-33.208, p = 0.033). Median overall survival of patients with CN and CHD was significantly shorter than OS of patients without CHD (7.8 vs. 13.1 years, p = 0.0045, HR 2.8437, 95 % CI 0.9818-8.2364).
CONCLUSIONS: In our study, CHD was the most important factor of survival in CN patients. For optimal management of CN, adequate diagnostics and treatment of CHD according to current guidelines should be considered.

Entities:  

Mesh:

Year:  2014        PMID: 25344769     DOI: 10.1007/s00592-014-0669-9

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  5 in total

1.  MDCT assessment of CAD in type-2 diabetic subjects with diabetic neuropathy: the role of Charcot neuro-arthropathy.

Authors:  Riccardo Marano; Dario Pitocco; Enrico Di Stasio; Giancarlo Savino; Biagio Merlino; Carlo Trani; Federica Pirro; Claudia Rutigliano; Carolina Santangelo; Aurelian Costin Minoiu; Luigi Natale; Lorenzo Bonomo
Journal:  Eur Radiol       Date:  2015-07-03       Impact factor: 5.315

2.  Letter to the Editor Regarding: Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study.

Authors:  Kalliopi Pafili; Nikolaos Papanas
Journal:  Adv Ther       Date:  2016-09-26       Impact factor: 3.845

3.  CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation.

Authors:  Bartosz Hudzik; Janusz Szkodziński; Michal Hawranek; Andrzej Lekston; Lech Poloński; Mariusz Gąsior
Journal:  Acta Diabetol       Date:  2016-06-23       Impact factor: 4.280

4.  Multi-System Factors Associated with Metatarsophalangeal Joint Deformity in Individuals with Type 2 Diabetes.

Authors:  Jennifer A Zellers; Michael J Mueller; Paul K Commean; Ling Chen; Hyo-Jung Jeong; Mary K Hastings
Journal:  J Clin Med       Date:  2020-04-03       Impact factor: 4.241

5.  Long-term follow-up of conservative treatment of Charcot feet.

Authors:  Viviane Gratwohl; Thorsten Jentzsch; Madlaina Schöni; Dominik Kaiser; Martin C Berli; Thomas Böni; Felix W A Waibel
Journal:  Arch Orthop Trauma Surg       Date:  2021-04-07       Impact factor: 2.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.